Cytomegalovirus prophylaxis strategies in high-risk transplantation.
Snydman
D R
DR
Department of Medicine, New England Medical Center, Boston, MA 02111.
D000998:Antiviral Agents / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use; D016756:Immunoglobulins, Intravenous; D016377:Organ Transplantation / Q000009:adverse effects*; D012307:Risk Factors
D000998:Antiviral Agents; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin